25 April 2022 in IEEE Transactions on Microwave Theory and Techniques
A self-coupled resonator consisting of asymmetrical parallel-coupled microstrip transmission lines is proposed to design wide stopband dual-band bandpass filters. Due to the even-to-odd-mode analysis limitation to asymmetrical structure, a multiport analysis method is developed and applied to analyze the proposed self-coupled resonator and dual-band filter. According to the analysis, the proposed self-coupled resonator features a small frequency ratio of the second to the first resonances and controllable spurious responses, and its transmission zeros (TZs) are placed close to the position out-of-band spurs in order to achieve wide stopband. Moreover, a feed line consisting of tapped line loaded coupled line is investigated, resulting in flexible adjustment of the second passband external quality factor ( ${ \boldsymbol Q}_{ \boldsymbol e}$ ) with a minor influence on the first passband ${ \boldsymbol Q}_{ \boldsymbol e}$ . A dual-band BPF prototype with a frequency ratio of 1.59 is proposed and validated. It is operated at 2.34 and 3.72 GHz with the insertion loss of 1.05 and 1.86 dB, respectively. A return loss better than 20 dB is achieved at both passbands. The out-of-band rejection is better than 30 dB within the frequency range from 4.19 to 11.24 GHz, and the harmonic suppression is 39.97 dB at 14.88 GHz and 61.41 dB at 18.6 GHz. The measured results verify the analytical method presented in this article well.
16 December 2021 in IEEE Microwave and Wireless Components Letters
This letter presents a fully integrated dual power mode Doherty power amplifier (PA) in the Nanjing Electronic Devices Institute (NEDI) 250-nm GaN process. Due to the advantages of high power (HP) and gain, the cascode architecture is introduced to both carrier and peaking PAs. To the author's best knowledge, this is the first time cascode architecture is applied in GaN process for sub-6 GHz Doherty PA design. The equivalent parasitic network and interstage impedance matching network of cascode transistors are constructed and extracted within the frequency range of 1-15 GHz. High efficiency voltage-current waveform at the current generator plane of carrier PA is achieved. The gate and drain bias of the common gate transistor are adjusted to attain low power (LP)/HP mode. A Doherty PA prototype operating in 5G NR FR1 n78 is presented with a saturated power of 36.5-37.2 dBm, a peaking power added efficiency (PAE) of 49.6%-52.0%, a 6-dB back-off PAE of 34.4%-39.6%, and a gain of 12.2-12.9 dB for LP mode. The realized high-gain saturated power is 39.8-40.5 dBm with a relatively HP density of 3.96 W/mm, a peaking PAE of 42.5%-47.7%, a 6-dB back-off PAE of 32.0%-37.8%, and a gain of 16.0-16.4 dB for HP mode.
23 September 2024 in medRxiv
Background: The mechanism driving multiple pathophysiological alterations in Alzheimer’s disease (AD) remains unclear. Thiamine deficiency, a well-known feature of AD, may contribute to these alterations. Methods: The expressions of four known genes associated with thiamine metabolism were studied in brain samples from patients with AD and other neurodegenerative disorders. The results were further demonstrated in AD and diabetic mouse and cellular models. The phenotypes of mice with conditional Thiamine pyrophosphokinase-1 ( Tpk ) knockout in brain excitatory neurons were investigated. The therapeutic effects of thiamine diphosphate supplement and Tpk delivery on cellular and mouse models were explored. Phase 2 clinical trial of benfotiamine, a thiamine derivative, plus donepezil was performed. Results: Only TPK expression was inhibited in brain samples of AD patients, while none of thiamine-associated genes were significantly changed in other neurodegenerative disorders. TPK inhibition in the brains and neurons was verified in AD and diabetic mouse and cellular models. Mice with Tpk deletion in neurons exhibited all major pathophysiological alterations of AD, including amyloid deposition, Tau hyperphosphorylation, and brain atrophy. TPK expression restoration and thiamine diphosphate supplement ameliorated the pathophysiological and behavioral phenotypes in mouse and cell models with Tpk insufficiency. Benfotiamine delayed cognitive decline in mild-to-moderate AD patients with a dose-effect relationship, particularly with a significant attenuation of the deterioration in moderate AD patients by post hoc analysis. Conclusions: TPK deficiency and hence thiamine diphosphate reduction in neurons are a decisive factor driving multiple pathophysiologic alterations of AD, unveiling a new direction for the disease mechanism and treatment.